Alzamend Neuro Inc (ALZN)

Dec 09, 2025

Alzamend Neuro, Inc. SEC 10-Q Report - TradingView

Dec 09, 2025

Dec 06, 2025

Is Alzamend Neuro Inc stock attractive for passive investorsWeekly Investment Summary & Weekly Top Gainers Alerts - BỘ NỘI VỤ

Dec 06, 2025

Dec 04, 2025

Why Alzamend Neuro Inc. stock remains undervaluedJuly 2025 Analyst Calls & High Accuracy Trade Alerts - Newser

Dec 04, 2025

Dec 01, 2025

Alzamend Neuro (ALZN) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 29, 2025

Alzamend Neuro Mourns Loss of Director Andrew Woo - MSN

Nov 29, 2025

Nov 27, 2025

Is Alzamend Neuro Inc. stock attractive for passive investors2025 Earnings Impact & Daily Profit Focused Stock Screening - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Alzamend Neuro: Will Topline Data Spark Investor Interest? - RTTNews

Nov 26, 2025

Nov 25, 2025

Alzamend Neuro's AL001 formulation highlights its potential to treat disorders such a Alzheimer's - SelectScience

Nov 25, 2025

Nov 21, 2025

What margin trends mean for Alzamend Neuro Inc. stockWeekly Market Outlook & Verified Swing Trading Watchlists - newser.com

Nov 21, 2025

Nov 21, 2025

Why Alzamend Neuro Inc. stock could see breakout soonProduct Launch & High Return Trade Opportunity Guides - newser.com

Nov 21, 2025

Nov 20, 2025

Why Alzamend Neuro Inc. stock could benefit from AI revolutionTrade Risk Report & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Can Alzamend Neuro Inc. stock sustain revenue growthMarket Risk Analysis & Pattern Based Trade Signal System - newser.com

Nov 20, 2025

Nov 19, 2025

Will Alzamend Neuro Inc. stock rally after Fed decisionsJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Alzamend Neuro Inc. stock reach all time highs in 2025Exit Point & Daily Technical Forecast Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Alzamend completes clinical portion of phase II trial for lithium therapy - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 13:20:00 - newser.com

Nov 19, 2025

Nov 19, 2025

Alzamend Neuro announces passing of board member Andrew H. Woo By Investing.com - Investing.com Australia

Nov 19, 2025

Nov 19, 2025

Comparing Alzamend Neuro Inc. in custom built stock radarsWeekly Risk Summary & Weekly Momentum Picks - newser.com

Nov 19, 2025

Nov 19, 2025

Alzamend Neuro announces completion of clinical portion of phase II clinical trial of AL001 "lithium in brain" study conducted at Massachusetts General Hospital - MarketScreener

Nov 19, 2025

Nov 19, 2025

Alzamend rises after completing mid-stage brain lithium study - TradingView

Nov 19, 2025

Nov 19, 2025

Alzamend Neuro (Nasdaq: ALZN) completes AL001 Phase II trial; 2026 lithium imaging data - Stock Titan

Nov 19, 2025

Nov 19, 2025

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants - Benzinga

Nov 19, 2025

Nov 19, 2025

Multi asset correlation models including Alzamend Neuro Inc.Oil Prices & Fast Exit/Entry Strategy Plans - newser.com

Nov 19, 2025

Nov 18, 2025

Is Alzamend Neuro Inc. stock cheap compared to fundamentalsWeekly Trend Summary & Safe Capital Growth Plans - newser.com

Nov 18, 2025

Nov 18, 2025

Alzamend Neuro announces passing of board member Andrew H. Woo - Investing.com

Nov 18, 2025

Nov 18, 2025

Alzamend Neuro Announces Passing of Board Member Andrew H. Woo - TradingView

Nov 18, 2025

Nov 18, 2025

[8-K] Alzamend Neuro, Inc. Reports Material Event | ALZN SEC FilingForm 8-K - Stock Titan

Nov 18, 2025